Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease

Penny, Lewis K; Lofthouse, Richard; Arastoo, Mohammad; Porter, Andy; Palliyil, Soumya; Harrington, Charles R; Wischik, Claude M

Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease

Files

s40035-024-00417-w.pdf (1.12 MB)

Date

2024-05-21

Authors

Harrington, Charles R

Wischik, Claude M

Citation

Penny, L K, Lofthouse, R, Arastoo, M, Porter, A, Palliyil, S, Harrington, C R & Wischik, C M 2024, 'Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease', Translational neurodegeneration, vol. 13, 25. https://doi.org/10.1186/s40035-024-00417-w